Non-viral carriers for nucleic acids delivery: Fundamentals and current applications

S Shtykalova, D Deviatkin, S Freund, A Egorova… - Life, 2023 - mdpi.com
Simple Summary Gene therapy is one of the most promising approaches to treating various
inherited and acquired diseases by delivering genetic constructs into the cells and tissues of …

Bioactive whey peptide particles: An emerging class of nutraceutical carriers

A Madadlou, A Abbaspourrad - Critical reviews in food science and …, 2018 - Taylor & Francis
Whey-based diets have been linked with prolonged life expectancy and improved physical
performance. These observations based on numerous clinical and simulated studies are …

Deciphering Structural Determinants Distinguishing Active from Inactive Cell-Penetrating Peptides for Cytosolic mRNA Delivery

RO Egberink, AH van Asbeck, M Boswinkel… - Bioconjugate …, 2023 - ACS Publications
The formation of noncovalent complexes by mixing of positively charged polymers with
negatively charged oligonucleotides (ONs) is a widely explored concept in nanomedicine to …

Serum-Resistant Ternary DNA Polyplexes for Suicide Gene Therapy of Uterine Leiomyoma

A Egorova, S Shtykalova, M Maretina, S Freund… - International Journal of …, 2023 - mdpi.com
Uterine leiomyoma (UL) is a prevalent benign tumor in women that frequently gives rise to a
multitude of reproductive complications. The use of suicide gene therapy has been …

Polycondensed peptide carriers modified with cyclic RGD ligand for targeted suicide gene delivery to uterine fibroid cells

A Egorova, S Shtykalova, M Maretina, A Selutin… - International Journal of …, 2022 - mdpi.com
Suicide gene therapy was suggested as a possible strategy for the treatment of uterine
fibroids (UFs), which are the most common benign tumors inwomen of reproductive age. For …

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells

A Egorova, A Selutin, M Maretina, S Selkov, A Kiselev - Molecules, 2022 - mdpi.com
Uterine leiomyoma is the most common benign tumor of the reproductive system. Current
therapeutic options do not simultaneously meet the requirements of long-term efficiency and …

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis

A Egorova, M Petrosyan, M Maretina, E Bazian… - Pharmaceutics, 2023 - mdpi.com
Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the
treatment of endometriosis (EM), which is the most common gynecological disease …

CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery

A Egorova, A Shubina, D Sokolov, S Selkov… - International journal of …, 2016 - Elsevier
The application of small interfering RNA (siRNA) for specific gene inhibition is a promising
strategy in gene therapy treatments. The efficient cellular delivery of therapeutic siRNA is a …

Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model

A Egorova, M Petrosyan, M Maretina, N Balashova… - Gene Therapy, 2018 - nature.com
Abstract Development of gene therapy for endometriosis requires inhibition of
vascularization in endometrial lesions. We have previously developed CXCR4 receptor …

Arginine-rich cross-linking peptides with different SV40 nuclear localization signal content as vectors for intranuclear DNA delivery

M Bogacheva, A Egorova, A Slita, M Maretina… - Bioorganic & Medicinal …, 2017 - Elsevier
The major barriers for intracellular DNA transportation by cationic polymers are their toxicity,
poor endosomal escape and inefficient nuclear uptake. Therefore, we designed novel …